GB8609033D0 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB8609033D0
GB8609033D0 GB868609033A GB8609033A GB8609033D0 GB 8609033 D0 GB8609033 D0 GB 8609033D0 GB 868609033 A GB868609033 A GB 868609033A GB 8609033 A GB8609033 A GB 8609033A GB 8609033 D0 GB8609033 D0 GB 8609033D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
compound
hydroxyethyl starch
contracting states
nootropic activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB868609033A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB SA
Original Assignee
UCB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10596143&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB8609033(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to GB868609033A priority Critical patent/GB8609033D0/en
Application filed by UCB SA filed Critical UCB SA
Publication of GB8609033D0 publication Critical patent/GB8609033D0/en
Priority to CA000530693A priority patent/CA1288347C/en
Priority to AT87870049T priority patent/ATE53494T1/en
Priority to DE8787870049T priority patent/DE3763141D1/en
Priority to EP87870049A priority patent/EP0243336B1/en
Priority to AU71477/87A priority patent/AU7147787A/en
Priority to DK189787A priority patent/DK189787A/en
Priority to JP62090606A priority patent/JPS62267226A/en
Priority to ZA872677A priority patent/ZA872677B/en
Priority to GR90400615T priority patent/GR3000758T3/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1. Claims for the Contracting States : BE, CH, DE, FR, GB, IT, LI, LU, NL, SE Pharmaceutical compositions, characterized in that they contain at least one hydroxyethyl starch and at least one compound having nootropic activity. 1. Claims for the Contracting States : AT, ES, GR Process for the preparation of pharmaceutical compositions, characterized in that at least one hydroxyethyl starch is mixed with at least one compound having nootropic activity.
GB868609033A 1986-04-14 1986-04-14 Pharmaceutical compositions Pending GB8609033D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GB868609033A GB8609033D0 (en) 1986-04-14 1986-04-14 Pharmaceutical compositions
CA000530693A CA1288347C (en) 1986-04-14 1987-02-26 Pharmaceutical compositions for the treatment of intermittent claudication
AT87870049T ATE53494T1 (en) 1986-04-14 1987-04-10 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHARCOT'S SYNDROME.
DE8787870049T DE3763141D1 (en) 1986-04-14 1987-04-10 PHARMACEUTICAL COMPOSITIONS FOR TREATING CHARCOT SYNDROME.
EP87870049A EP0243336B1 (en) 1986-04-14 1987-04-10 Pharmaceutical compositions for the treatment of intermittent claudication
AU71477/87A AU7147787A (en) 1986-04-14 1987-04-13 Pharmaceutical compositions of an hydroxyethyl starch and a nootropic drug
JP62090606A JPS62267226A (en) 1986-04-14 1987-04-13 Medicinal composition, manufacture and remedy for intermittent lameness patient
DK189787A DK189787A (en) 1986-04-14 1987-04-13 PHARMACEUTICAL PREPARATIONS FOR TREATING CLAUDICATIO INTERMITTEN
ZA872677A ZA872677B (en) 1986-04-14 1987-04-14 Pharmaceutical compositions for the treatment of intermittent claudication
GR90400615T GR3000758T3 (en) 1986-04-14 1990-09-06 Pharmaceutical compositions for the treatment of intermittent claudication

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868609033A GB8609033D0 (en) 1986-04-14 1986-04-14 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
GB8609033D0 true GB8609033D0 (en) 1986-05-21

Family

ID=10596143

Family Applications (1)

Application Number Title Priority Date Filing Date
GB868609033A Pending GB8609033D0 (en) 1986-04-14 1986-04-14 Pharmaceutical compositions

Country Status (10)

Country Link
EP (1) EP0243336B1 (en)
JP (1) JPS62267226A (en)
AT (1) ATE53494T1 (en)
AU (1) AU7147787A (en)
CA (1) CA1288347C (en)
DE (1) DE3763141D1 (en)
DK (1) DK189787A (en)
GB (1) GB8609033D0 (en)
GR (1) GR3000758T3 (en)
ZA (1) ZA872677B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7608636B2 (en) * 2000-12-28 2009-10-27 Hamilton Pharmaceuticals, Inc. Medicines for treatment and prevention of neurogenic pain
CN106943377A (en) * 2016-06-15 2017-07-14 重庆润泽医药有限公司 A kind of levo-oxiracetam particle and preparation method thereof
CN106943376B (en) * 2016-06-15 2018-10-23 重庆润泽医药有限公司 A kind of levo-oxiracetam particle and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5027884A (en) * 1973-07-12 1975-03-22
DE3030863A1 (en) * 1980-08-14 1982-03-11 Albrecht M. Prof. Dr.med. 6072 Dreieich Ehrly Hydroxyethyl starch as infusion for treating circulatory disorders - increases tissue oxygen pressure, reduces blood viscosity and reduces aggregation of red blood platelets

Also Published As

Publication number Publication date
DK189787A (en) 1987-10-15
EP0243336A1 (en) 1987-10-28
JPS62267226A (en) 1987-11-19
AU7147787A (en) 1987-10-15
DE3763141D1 (en) 1990-07-19
ZA872677B (en) 1987-10-05
GR3000758T3 (en) 1991-10-10
CA1288347C (en) 1991-09-03
ATE53494T1 (en) 1990-06-15
DK189787D0 (en) 1987-04-13
EP0243336B1 (en) 1990-06-13

Similar Documents

Publication Publication Date Title
PH31617A (en) Novel thienylcarboxylates of amino alcohols, theirquaternary products and use of these compounds.
PT84449A (en) Process for the preparation of 3,5-disubstituted pyrocatechole derivatives and of pharmaceutical compositions containing the same
HUT45692A (en) Acaricide compositions containing 1-aralkyl-pyrazoles as active components and process for producing the new active components
IE812075L (en) Composition
HUT44135A (en) Herbicide compositions containing triazol-sulfonamide derivatives as active components and process for producing the active components
HUT41203A (en) Herbicide compositions containing 2-/2-comma above-substituted benzoyl/-1,3-cyclomexene-dione derivatives as active agents and process for producing the active agents
DE3563623D1 (en) Novel 1,5-benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions
PT86362A (en) Process for the preparation of anxiolytic compositions containing n-(1-azabicyclo ]2,2.2."-oct-3-yl) benzamides and thiobenzamides
AU8201087A (en) Polyamide rheological additive, a solution containing the additive and thickened compositions containing the additive
HUT45694A (en) Herbicide and growth-controllong compositions containing 5-amino-1-phenyl-pyrazoles as active components and process for producing the active components
HUT44131A (en) Herbicide compositions containing pyrazolo-pyrimidine derivatives as active components and process for producing the active components
HUT44130A (en) Herbicide compositions containing thiazolo-triazol-sulfonamide derivatives as active components and process for producing the active components
HUT44134A (en) Herbicide compositions containing triazolo-sulfonamide derivatives as active components and process for producing the active components
SG58994G (en) Aralkylaminoalkoxyphenyl derivatives, process of preparation and compositions containing the same
HUT46688A (en) Fungicide compositions containing carbamoyl-imidazol derivatives as active components and process for producing the active components
HUT39962A (en) Herbicide compositions containing 2,4-diamino-pyrimidine derivatives as active ingredients and process for preparing the active ingredients
EP0264744A3 (en) Process for the preparation of 4,4'-diaminodiphenylmethane and its derivatives.
HUT41230A (en) Pesticide compositions containing substituted 4,5-dihydro-1,3,4-thiadiazol derivatives as active agents and process for producing the active agents
JPS6468310A (en) Trichogenous and hair-tonic agent
GB8609033D0 (en) Pharmaceutical compositions
HK182795A (en) Composition useful in the treatment of estrogen deficiencies
PT85054A (en) Process for the preparation of fused imidazoheterocyclic compounds and of pharmaceutical compositions containing the same
HUT46838A (en) Pesticide compositions containing 2,5-bis-pyridyl-1,3,4-thiadiazol derivatives as active components and process for producing the active components
GB8706267D0 (en) Superalloy compositions & articles
HUT45696A (en) Insekticide and acaricide compositions containing new benzoyl-urea derivatives as active components and process for producing the active components